Trial Profile
A Study Of Metabolic Factors And Efficacy Of Pentoxifylline Versus Pioglitazone In Lean And Obese Nash (Non-Alcoholic Steatohepatitis) Patients.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Pentoxifylline (Primary) ; Pioglitazone (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Therapeutic Use
- 28 Feb 2017 New trial record